DON’T MISS
IamExpat FairIamExpat Job BoardIamExpat Webinars
Newsletters
EXPAT INFO
CAREER
HOUSING
EDUCATION
LIFESTYLE
EXPAT SERVICES
NEWS & ARTICLES
Home
Expat Info
Dutch news & articles
Netherlands signs deal with EU nations for coronavirus vaccine
Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy

Netherlands signs deal with EU nations for coronavirus vaccine

Never miss a thing!Sign up for our weekly newsletters with important news stories, expat events and special offers.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy
or
follow us for regular updates:



Related Stories

Coronavirus restrictions in Netherlands cause decline in other infectionsCoronavirus restrictions in Netherlands cause decline in other infections
Netherlands: Coronavirus tracked to 12 days before first caseNetherlands: Coronavirus tracked to 12 days before first case
The Corona Check app is now available to the Dutch publicThe Corona Check app is now available to the Dutch public
Three percent of people may have developed Covid-19 antibodiesThree percent of people may have developed Covid-19 antibodies
How is the Coronavirus affecting international students in the Netherlands?How is the Coronavirus affecting international students in the Netherlands?
Primary school in the Netherlands shuts for summer due to COVID-19Primary school in the Netherlands shuts for summer due to COVID-19
Opinion in the Netherlands divided over coronavirus tracking appOpinion in the Netherlands divided over coronavirus tracking app
Netherlands offered 5000 extra tests per day by German laboratoryNetherlands offered 5000 extra tests per day by German laboratory
For expats of all colours, shapes and sizes

Explore
Expat infoCareerHousingEducationLifestyleExpat servicesNews & articles
About us
IamExpat MediaAdvertisePost a jobContact usSitemap
More IamExpat
IamExpat Job BoardIamExpat HousingIamExpat FairsWebinarsNewsletters
Privacy
Terms of usePrivacy policyCookiesAvoiding scams

Never miss a thing!Sign up for expat events, news & offers, delivered once a week.
Keep me updated with exclusive offers from partner companies
By signing up, you agree that we may process your information in accordance with our privacy policy


© 2025 IamExpat Media B.V.
© 2025 IamExpat Media B.V.
Jun 15, 2020
William Nehra
William studied a masters in Classics at the University of Amsterdam. He is a big fan of Ancient History and football, particularly his beloved Watford FC. Read more

The Netherlands, along with Germany, France and Italy have signed collectively signed a contract for 300 million doses of a coronavirus vaccine that is still currently under development.

The coronavirus vaccine alliance

On Saturday, it was confirmed that four countries: Germany, France, Italy and the Netherlands have signed a collective agreement with AstraZeneca, the British-Swedish multinational pharmaceutical company.

The terms of the deal have not been disclosed; however, the four countries have paid for the vaccines among themselves. The vaccinations, which could potentially rise to 400 million doses, will be shared across all EU member states that want to participate. If the vaccine is approved, it will be distributed around participating countries according to their population. The population of the EU is around 446 million.

The European Commission has shown its inclination towards advance purchase contracts that will allow guaranteed access to a future vaccine, although the Commission has stated it would prefer to negotiate deals on behalf of EU member states itself.

The race for a vaccine

The vaccine, which is being provided by AstraZeneca, was developed by the University of Oxford and is one of just a few vaccines that are currently in the clinical evaluation phase. The university began clinical trials in April and is now increasing their scope to 10.000 participants.

Since the coronavirus pandemic spread across the world, laboratories everywhere have been racing to develop a vaccine. Instead of the typical few years it takes to develop a vaccine, government sources say that the vaccine could be ready by the end of the year, in just 12-18 months since development began.

By William Nehra